Patent · US Active

Mycoplasma hyopneumoniae vaccine

US9120859B2 · kind B2 · utility

9Cited by
45References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 26, 2013
Grant dateSep 1, 2015
Priority date
Expiry dateMar 26, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2770/10034
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides an immunogenic composition including a soluble portion of a Mycoplasma hyopneumoniae (M.hyo) whole cell preparation, wherein the soluble portion of the M.hyo preparation is substantially free of both (i) IgG and (ii) immunocomplexes comprised of antigen bound to immunoglobulin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.